HK Stock MarketDetailed Quotes
09995 REMEGEN
- 16.740
- -1.320-7.31%
Market Closed Nov 22 16:08 CST
9.11BMarket Cap-5294P/E (TTM)
18.280High16.600Low2.35MVolume18.060Open18.060Pre Close39.99MTurnover1.24%Turnover RatioLossP/E (Static)544.33MShares46.70052wk High3.47P/B3.17BFloat Cap10.20052wk Low--Dividend TTM189.58MShs Float149.800Historical High--Dividend LFY9.30%Amplitude10.200Historical Low17.030Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
REMEGEN Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 57.10%1.21B | 76.50%739.66M | 96.41%330.43M | 40.16%1.08B | 35.08%769.47M | 20.15%419.07M | 12.06%168.24M | -46.08%767.78M | 397.47%569.64M | 1,094.78%348.78M |
| Operating income | 57.10%1.21B | 76.50%739.66M | 96.41%330.43M | 40.16%1.08B | 35.08%769.47M | 20.15%419.07M | 12.06%168.24M | -46.08%767.78M | 397.47%569.64M | 1,094.78%348.78M |
| Cost of sales | ---- | -64.89%-169.27M | ---- | 6.22%-253.14M | ---- | 38.72%-102.66M | ---- | -301.92%-269.94M | ---- | -3,510.02%-167.51M |
| Operating expenses | -37.65%-244.74M | -64.89%-169.27M | -196.17%-74.36M | 6.22%-253.14M | 20.47%-177.8M | 38.72%-102.66M | 74.25%-25.11M | -301.92%-269.94M | -2,079.96%-223.57M | -3,510.02%-167.51M |
| Gross profit | 62.95%964.13M | 80.26%570.39M | 78.91%256.08M | 65.31%822.99M | 70.97%591.67M | 74.55%316.42M | 171.98%143.13M | -63.31%497.84M | 231.95%346.06M | 638.33%181.27M |
| Selling expenses | -15.36%-622.7M | -11.28%-389.67M | -18.81%-187.5M | -75.90%-775.19M | -94.41%-539.79M | -133.51%-350.17M | -95.36%-157.82M | -67.59%-440.7M | -115.68%-277.66M | -146.27%-149.96M |
| Administrative expenses | 3.39%-234.62M | 7.94%-155.22M | 5.70%-74.26M | -15.09%-313.67M | -51.17%-242.87M | -57.70%-168.61M | -60.52%-78.75M | -23.97%-272.54M | -0.86%-160.66M | -8.42%-106.92M |
| Research and development expenses | -34.43%-1.15B | -49.18%-806.23M | -32.62%-331.18M | -33.01%-1.31B | -29.50%-857.98M | -20.19%-540.45M | -14.46%-249.72M | -38.13%-982.08M | -26.29%-662.54M | -37.68%-449.67M |
| Profit from asset sales | --88.36K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -3.02%15.5K | ---- |
| Revaluation surplus | -86.10%718.29K | ---- | -101.81%-49.46K | ---- | -55.15%5.17M | ---- | --2.73M | ---- | --11.53M | ---- |
| -Changes in the fair value of other assets | -86.10%718.29K | ---- | -101.81%-49.46K | ---- | -55.15%5.17M | ---- | --2.73M | ---- | --11.53M | ---- |
| Impairment and provision | -5.77%-15.78M | 7.30%-3.81M | -346.42%-4.66M | -1.33%-11.28M | -63.53%-14.92M | 26.58%-4.11M | 229.03%1.89M | -3,153.80%-11.13M | -1,814.98%-9.12M | -2,386.67%-5.6M |
| -Other impairment is provision | -5.77%-15.78M | 7.30%-3.81M | -346.42%-4.66M | -1.33%-11.28M | -63.53%-14.92M | 26.58%-4.11M | 229.03%1.89M | -3,153.80%-11.13M | -1,814.98%-9.12M | -2,386.67%-5.6M |
| Special items of operating profit | 87.59%66.48M | -27.46%35.95M | 2.19%11.78M | -55.96%95.35M | 32.59%35.44M | 12.83%49.56M | 55.95%11.53M | 82.02%216.54M | 43.26%26.73M | 117.26%43.92M |
| Operating profit | 2.21%-1.01B | -7.35%-748.59M | -1.58%-334.24M | -50.00%-1.49B | -40.94%-1.03B | -43.21%-697.37M | -13.06%-329.03M | -452.32%-992.07M | -5.41%-730.19M | -10.28%-486.95M |
| Financing cost | -1,239.27%-49.5M | -431.38%-31.87M | -256.14%-10.71M | -241.73%-23.09M | -91.90%4.34M | -175.72%-6M | -17.79%6.86M | -26.94%-6.76M | 128.81%53.61M | 11.94%-2.18M |
| Share of profits of associates | ---- | ---- | ---- | ---45K | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of earning before tax | -169.36%-15.56M | ---- | -147.00%-3.97M | ---- | 50.34%-5.78M | ---- | 61.33%-1.61M | ---- | 38.68%-11.64M | ---- |
| Earning before tax | -3.96%-1.07B | -10.96%-780.46M | -7.77%-348.92M | -51.30%-1.51B | -49.75%-1.03B | -43.80%-703.36M | -12.88%-323.77M | -461.56%-998.83M | 0.01%-688.22M | -10.15%-489.13M |
| After-tax profit from continuing operations | -3.96%-1.07B | -10.96%-780.46M | -7.77%-348.92M | -51.30%-1.51B | -49.75%-1.03B | -43.80%-703.36M | -12.88%-323.77M | -461.56%-998.83M | 0.01%-688.22M | -10.15%-489.13M |
| Earning after tax | -3.96%-1.07B | -10.96%-780.46M | -7.77%-348.92M | -51.30%-1.51B | -49.75%-1.03B | -43.80%-703.36M | -12.88%-323.77M | -461.56%-998.83M | 0.01%-688.22M | -10.15%-489.13M |
| Profit attributable to shareholders | -3.96%-1.07B | -10.96%-780.46M | -7.77%-348.92M | -51.30%-1.51B | -49.75%-1.03B | -43.80%-703.36M | -12.88%-323.77M | -461.56%-998.83M | 0.01%-688.22M | -10.15%-489.13M |
| Basic earnings per share | -4.19%-1.99 | -11.54%-1.45 | -8.33%-0.65 | -48.94%-2.8 | -44.70%-1.91 | -35.42%-1.3 | -1.69%-0.6 | -429.82%-1.88 | 6.38%-1.32 | -5.49%-0.96 |
| Diluted earnings per share | -4.19%-1.99 | -11.54%-1.45 | -8.33%-0.65 | -48.94%-2.8 | -44.70%-1.91 | -35.42%-1.3 | -1.69%-0.6 | -429.82%-1.88 | 6.38%-1.32 | -5.49%-0.96 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data